Biotechnology · Cambridge, United Kingdom · Founded 2016 · Privately Held (backing)
Developer of a synthetic biology platform designed to provide human cells for research, drug discovery and cell therapy. bit.bio is based in Cambridge, United Kingdom and was founded in 2016. It was valued at $546 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $234 million across 1 recorded round; the latest was a $138 million later-stage round in Dec 2021.
PMV mark · valuation
$546.3M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$234.2M
Last round
Later Stage VC
Dec 2021
Team — not yet on record
No current team members for bit.bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of bit.bio with a free account
·The complete investor list: 35 names
·Watch bit.bio: the Monday email on marks, rounds and moves
